MX9702769A - Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek. - Google Patents

Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek.

Info

Publication number
MX9702769A
MX9702769A MX9702769A MX9702769A MX9702769A MX 9702769 A MX9702769 A MX 9702769A MX 9702769 A MX9702769 A MX 9702769A MX 9702769 A MX9702769 A MX 9702769A MX 9702769 A MX9702769 A MX 9702769A
Authority
MX
Mexico
Prior art keywords
marek
production
cell line
disease vaccines
sustainable cell
Prior art date
Application number
MX9702769A
Other languages
English (en)
Inventor
Paul M Coussens
John David Reilly
Amin Abujoub
Original Assignee
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/670,272 external-priority patent/US5833980A/en
Application filed by Univ Michigan State filed Critical Univ Michigan State
Publication of MX9702769A publication Critical patent/MX9702769A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion describe líneas de células de pollo que contienen el Virus de la Enfermedad de Marek (VEM), el cual está presente como una infeccion no lítica o una lítica de la línea de células, y un método de produccion. También están descritos métodos y vacunas contra el VEM aviar preparadas a partir de las líneas de células.
MX9702769A 1996-06-21 1997-04-16 Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek. MX9702769A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/670,272 US5833980A (en) 1995-10-27 1996-06-21 Sustainable cell line for the production of the Marek's disease vaccines

Publications (1)

Publication Number Publication Date
MX9702769A true MX9702769A (es) 1997-12-31

Family

ID=24689728

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702769A MX9702769A (es) 1996-06-21 1997-04-16 Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek.

Country Status (8)

Country Link
JP (1) JPH104956A (es)
KR (1) KR980002250A (es)
CN (1) CN1170760A (es)
AR (1) AR007611A1 (es)
AU (1) AU697814B2 (es)
BR (1) BR9703544A (es)
ID (1) ID19429A (es)
MX (1) MX9702769A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2775218T3 (es) * 2011-11-30 2020-07-24 Boehringer Ingelheim Animal Health Usa Inc Vectores HVT recombinantes que expresan antígenos de patógenos aviares y usos de los mismos
JP2013116869A (ja) * 2011-12-02 2013-06-13 Vaxxinova Kk 細胞内在ウイルスを主成分とする伝染性ファブリキウス嚢病生ワクチン
CN103977400B (zh) * 2014-05-29 2015-06-17 南京创启生物科技有限公司 一种用细胞系生产鸡马立克氏病活疫苗的方法

Also Published As

Publication number Publication date
AR007611A1 (es) 1999-11-10
AU697814B2 (en) 1998-10-15
JPH104956A (ja) 1998-01-13
BR9703544A (pt) 1998-09-29
CN1170760A (zh) 1998-01-21
AU2356897A (en) 1998-01-08
KR980002250A (ko) 1998-03-30
ID19429A (id) 1998-07-09

Similar Documents

Publication Publication Date Title
MX9604907A (es) Vacuna de combinacion de virus para la enfermedad de newcastle.
TNSN97109A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
HUP9902790A2 (hu) Madarakban alkalmazható polinukleotid-vakcinakészítmények
ATE110950T1 (de) Hüftprothese.
CA2132328A1 (en) Vaccine Containing Live Virus for Therapy of Viral Diseases and Malignancies
EP1026246A4 (en) RECOMBINANTS OF INFECTIOUS BIRD HERPESVIRUS AND RECOMBINANT VACCINES PRODUCED WITH THEIR USE
GB9814538D0 (en) Helicobacter pylori bacterioferritin
BG102809A (en) Vaccine against the reproductive and respiratory syndrome in pigs
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
DE69735591D1 (de) Impfstoff auf einem plasmid beruhend zur behandlung von atherosclerosis
AU1578788A (en) Viral vector system for the introduction of foreign dna expression products into gallinaceous birds
MX9702769A (es) Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek.
AU6698900A (en) Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
HUT38542A (en) Process for preparing a living vaccine against marek disease
MX9602256A (es) Vacuna contra la enfermedad de marek.
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
HU9502128D0 (en) Marek's disease virus vaccine
EP0496135A3 (en) Cell free marek's disease virus vaccine
ZA997114B (en) Processes for preparation of Marek's Disease Virus using continuous avian cell lines.
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
PL341724A1 (en) Mutated newcastle disease virus (ndv) and method of obtaining same, live or inactivated vaccine containing same and method of obtaining such vaccine
EP1074624A4 (en) GENE 62 OF THE ATTENUATED VARICELLA VIRUS STRAIN OKA AND METHOD FOR IDENTIFYING THE VIRUS STRAIN ATTENUATED VARICELLA VACCINE USING THE SAME
NZ333213A (en) Modified live avian polyomavirus vaccine in psittaciformes
IL78343A0 (en) Newcastle's disease virus(ndv)vaccine and method for the application thereof